Medtronic recalls MiniMed 700G insulin pumps (MMT-1801, MMT-1805, MMT-1850, MMT-1851) due to potential insulin over- or under-delivery when pump height changes, risking severe hypoglycemia or hyperglycemia.
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
Medtronic is recalling MiniMed 700G insulin pumps with specific model numbers because they can deliver too much or too little insulin if the pump is moved up or down relative to the injection site. This could cause life-threatening low blood sugar or high blood sugar conditions.
The pump can deliver too much insulin if raised above the injection site, causing severe low blood sugar that may lead to seizures or death. It can also deliver too little insulin if lowered below the injection site, causing severe high blood sugar that may lead to dehydration or diabetic ketoacidosis.
People with diabetes who use the MiniMed 700G insulin pump are affected. Those with insulin pumps that have the specific model numbers listed are most at risk.
Check the pump's model numbers: MMT-1801, MMT-1805, MMT-1850, or MMT-1851. These pumps were sold with specific serial numbers listed in the user guide.
Identify your pump model by checking the label on the pump for the model numbers MMT-1801, MMT-1805, MMT-1850, or MMT-1851.
Keep track of blood sugar levels closely as the pump may deliver incorrect insulin amounts when moved up or down relative to the injection site.
The affected model numbers are MMT-1801, MMT-1805, MMT-1850, and MMT-1851.
The pump can deliver too much insulin if raised above the injection site, causing severe low blood sugar that may lead to seizures or death. It can also deliver too little insulin if lowered below the injection site, causing severe high blood sugar that may lead to dehydration or diabetic ketoacidosis.
No, but you should monitor blood sugar levels closely and check if your pump model is affected. The recall does not require immediate discontinuation but requires careful use.
We’ve drafted a message you can send Medtronic to request your refund or repair — edit it as you like.
Subject: Recall Z-1744-2026 — Medtronic Medtronic Hello, I own a Medtronic that is covered by recall Z-1744-2026 from Medtronic. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
